Genetically engineered fixed K562 cells: potent “off the shelf” antigen presenting cells for generating virus specific T cells

BACKGROUND AIMS: The human leukemia cell line K562 represents an attractive platform for creating artificial antigen presenting cells (aAPC). It is readily expandable, does not express HLA class I and II and can be stably transduced with various genes. METHODS: In order to generate CMV antigen-speci...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cytotherapy
Päätekijät: Tanimoto, Kazushi, Muranski, Pawel, Miner, Samantha, Fujiwara, Hiroshi, Kajigaya, Sachiko, Keyvanfar, Keyvan, Hensel, Nancy, Barrett, A. John, Melenhorst, J. Joseph
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755681/
https://ncbi.nlm.nih.gov/pubmed/24176543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2013.08.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia